Talphera (TLPH)

• Market cap: $45.2M
• 1 day: 0.94%
• 5 days: -3.48%
• 1 month: 10.94%
• 3 months: 5.49%
• 6 months: -29.17%
• Year to date: -24.28%
• 1 year: 70.54%
• 5 years: -96.15%
• 10 years: -98.65%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Employees: 12